Speciation analysis of Sb(III) and Sb(V) in antileishmaniotic drug using Dowex 1×4 resin from hydrochloric acid solution
Authors:
- 5 September 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 52 (5) , 747-751
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Speciation of Sb(III) and Sb(V) in meglumine antimoniate pharmaceutical formulations by PSA using carbon nanotube electrodeJournal of Pharmaceutical and Biomedical Analysis, 2009
- Antimony in the environment as a global pollutant: A review on analytical methodologies for its determination in atmospheric aerosolsTalanta, 2008
- Speciation of antimony (III) and antimony (V) using hydride generation for meglumine antimoniate pharmaceutical formulationsquality controlMemórias do Instituto Oswaldo Cruz, 2008
- Speciation of antimony by adsorptive stripping voltammetry using pyrogallolTalanta, 2007
- Simultaneous determination of antimony(III) and antimony(V) by UV–vis spectroscopy and partial least squares method (PLS)Talanta, 2005
- Determination of antimony(iii) and total antimony by hydride generation atomic absorption spectrometry in samples of injectable drugs used for leishmaniasis treatmentJournal of Analytical Atomic Spectrometry, 2002
- Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasisAnalytical and Bioanalytical Chemistry, 2001
- Physico-chemical characterization of meglumine antimoniateBioMetals, 1999
- Characterization of the Antimonial Antileishmanial Agent Meglumine Antimonate (Glucantime)Antimicrobial Agents and Chemotherapy, 1998
- A simple spectrophotometric procedure for the determination of antimony (III) and (V) in antileishmanial drugsAnalytical and Bioanalytical Chemistry, 1997